Revisión
Los inhibidores de las proteínas-cinasas en enfermedades autoinmunes e inflamatorias: presente y futuro de nuevas dianas terapéuticas
Protein-kinase inhibitors: A new treatment pathway for autoimmune and inflammatory diseases?
Diana Hernández-Flórez, Lara Valor
Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, España
Leído
111147
Vecesse ha leído el artículo
12867
Total PDF
98280
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 42 | 82 | 124 |
| 2025 9 | 0 | 82 | 82 |
| 2025 8 | 0 | 131 | 131 |
| 2025 7 | 0 | 107 | 107 |
| 2025 6 | 33 | 52 | 85 |
| 2025 5 | 860 | 112 | 972 |
| 2025 4 | 846 | 104 | 950 |
| 2025 3 | 1087 | 121 | 1208 |
| 2025 2 | 973 | 118 | 1091 |
| 2025 1 | 879 | 136 | 1015 |
| 2024 12 | 772 | 130 | 902 |
| 2024 11 | 1108 | 144 | 1252 |
| 2024 10 | 826 | 112 | 938 |
| 2024 9 | 936 | 103 | 1039 |
| 2024 8 | 760 | 124 | 884 |
| 2024 7 | 729 | 112 | 841 |
| 2024 6 | 781 | 139 | 920 |
| 2024 5 | 949 | 130 | 1079 |
| 2024 4 | 920 | 152 | 1072 |
| 2024 3 | 735 | 119 | 854 |
| 2024 2 | 645 | 85 | 730 |
| 2024 1 | 736 | 85 | 821 |
| 2023 12 | 662 | 84 | 746 |
| 2023 11 | 1084 | 113 | 1197 |
| 2023 10 | 1163 | 121 | 1284 |
| 2023 9 | 1298 | 90 | 1388 |
| 2023 8 | 814 | 100 | 914 |
| 2023 7 | 687 | 92 | 779 |
| 2023 6 | 978 | 94 | 1072 |
| 2023 5 | 1122 | 119 | 1241 |
| 2023 4 | 788 | 110 | 898 |
| 2023 3 | 1268 | 156 | 1424 |
| 2023 2 | 1250 | 103 | 1353 |
| 2022 1 | 894 | 88 | 982 |
| 2022 12 | 768 | 93 | 861 |
| 2022 11 | 1551 | 145 | 1696 |
| 2022 10 | 1648 | 173 | 1821 |
| 2022 9 | 1397 | 172 | 1569 |
| 2022 8 | 1085 | 128 | 1213 |
| 2022 7 | 1042 | 181 | 1223 |
| 2022 6 | 1073 | 217 | 1290 |
| 2022 5 | 1281 | 212 | 1493 |
| 2022 4 | 1274 | 222 | 1496 |
| 2022 3 | 1359 | 206 | 1565 |
| 2022 2 | 1012 | 196 | 1208 |
| 2021 1 | 976 | 222 | 1198 |
| 2021 12 | 980 | 171 | 1151 |
| 2021 11 | 1448 | 173 | 1621 |
| 2021 10 | 1531 | 224 | 1755 |
| 2021 9 | 1562 | 207 | 1769 |
| 2021 8 | 1000 | 208 | 1208 |
| 2021 7 | 968 | 179 | 1147 |
| 2021 6 | 1245 | 200 | 1445 |
| 2021 5 | 1429 | 233 | 1662 |
| 2021 4 | 2746 | 310 | 3056 |
| 2021 3 | 1903 | 227 | 2130 |
| 2021 2 | 1448 | 176 | 1624 |
| 2020 1 | 1150 | 162 | 1312 |
| 2020 12 | 1623 | 138 | 1761 |
| 2020 11 | 1787 | 229 | 2016 |
| 2020 10 | 1344 | 177 | 1521 |
| 2020 9 | 1455 | 206 | 1661 |
| 2020 8 | 1326 | 115 | 1441 |
| 2020 7 | 1956 | 178 | 2134 |
| 2020 6 | 2310 | 191 | 2501 |
| 2020 5 | 1954 | 197 | 2151 |
| 2020 4 | 2437 | 242 | 2679 |
| 2020 3 | 1394 | 163 | 1557 |
| 2020 2 | 1270 | 131 | 1401 |
| 2020 1 | 1090 | 124 | 1214 |
| 2019 12 | 1110 | 110 | 1220 |
| 2019 11 | 1229 | 111 | 1340 |
| 2019 10 | 1505 | 129 | 1634 |
| 2019 9 | 1115 | 121 | 1236 |
| 2019 8 | 924 | 127 | 1051 |
| 2019 7 | 840 | 87 | 927 |
| 2019 6 | 934 | 124 | 1058 |
| 2019 5 | 1210 | 109 | 1319 |
| 2019 4 | 669 | 70 | 739 |
| 2019 3 | 588 | 115 | 703 |
| 2019 2 | 349 | 60 | 409 |
| 2019 1 | 289 | 60 | 349 |
| 2018 12 | 580 | 77 | 657 |
| 2018 11 | 774 | 20 | 794 |
| 2018 10 | 410 | 26 | 436 |
| 2018 9 | 427 | 19 | 446 |
| 2018 8 | 325 | 27 | 352 |
| 2018 7 | 204 | 8 | 212 |
| 2018 6 | 1 | 1 | 2 |
| 2018 5 | 47 | 2 | 49 |
| 2018 4 | 348 | 22 | 370 |
| 2018 3 | 304 | 31 | 335 |
| 2018 2 | 251 | 34 | 285 |
| 2018 1 | 211 | 20 | 231 |
| 2017 12 | 226 | 21 | 247 |
| 2017 11 | 314 | 19 | 333 |
| 2017 10 | 384 | 17 | 401 |
| 2017 9 | 331 | 38 | 369 |
| 2017 8 | 183 | 26 | 209 |
| 2017 7 | 243 | 28 | 271 |
| 2017 6 | 310 | 44 | 354 |
| 2017 5 | 351 | 37 | 388 |
| 2017 4 | 266 | 58 | 324 |
| 2017 3 | 356 | 59 | 415 |
| 2017 2 | 433 | 71 | 504 |
| 2016 1 | 173 | 37 | 210 |
| 2016 12 | 207 | 37 | 244 |
| 2016 11 | 304 | 48 | 352 |
| 2016 10 | 305 | 59 | 364 |
| 2016 9 | 344 | 43 | 387 |
| 2016 8 | 312 | 43 | 355 |
| 2016 7 | 138 | 42 | 180 |
| 2016 5 | 1 | 0 | 1 |
| 2016 4 | 8 | 152 | 160 |
Mostrar todo
